Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IRADIMED CORP
Report date February 11, 2022 · Filed February 12, 2022
Section 16 reporting ended · disclosed 2020-12-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,710 |
Reported balance
After 2022-02-11 transaction · row 1
1 source rowRow 1 · 2022-02-11 · Sale · Disposed 19,286 · Balance 13,710 F1: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2022 Filed Feb 12, 2022 02:34 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 19,286 | $50.06 | $965,424.37 |
DisclosureSEC source: 0000898432-22-000100 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,710 F1 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · derivative · entry 8 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,463 Underlying: Common Stock · 2,731 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F8 · derivative.exercise_date: On December 7, 2020, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F8 · derivative.expiration_date: On December 7, 2020, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · derivative · entry 7 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Common Stock · 1,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F7 · derivative.expiration_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantPerformance-Based Restricted Stock Units · Derivative | 4,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · derivative · entry 6 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F4 · derivative.exercise_date: The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2021 through December 7, 2024. F5 · derivative.exercise_date: If the relative measure at December 7, 2024 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100% and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting will be double the nominal granted shares. F6 · derivative.exercise_date: Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. F4 · derivative.expiration_date: The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2021 through December 7, 2024. F5 · derivative.expiration_date: If the relative measure at December 7, 2024 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100% and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting will be double the nominal granted shares. F6 · derivative.expiration_date: Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 4,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · derivative · entry 5 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 1,076 | $48.27 | $51,938.52 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · nonDerivative · entry 4 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,996 Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,732 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · nonDerivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 620 | $48.27 | $29,927.40 |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,340 Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 02:37 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000770 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2021 Filed Dec 8, 2021 21:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000756 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2021 Filed Dec 8, 2021 21:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 1,162 | $44.41 | $51,604.42 |
DisclosureSEC source: 0000898432-21-000756 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,385 Read SEC document |
| December 04, 2021 Filed Dec 8, 2021 21:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000756 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 22:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 26,715 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-21-000738 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,715 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 22:57 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 26,715 | $40.98 | $1,094,692.54 |
DisclosureSEC source: 0000898432-21-000738 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 F1 · price: This transaction was executed in multiple trades at prices ranging from $40.58 to $41.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 22:57 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 26,715 | $9.84 | $262,875.60 |
DisclosureSEC source: 0000898432-21-000738 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,310 Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,003 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · derivative · entry 9 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,715 Underlying: Common Stock · 2,003 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,003 | $40.01 | $80,141.03 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 6 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 2,003 | $9.84 | $19,709.52 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 5 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,598 Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,255 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · derivative · entry 8 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,718 Underlying: Common Stock · 4,255 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,255 | $40.00 | $170,200.00 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 4 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 4,255 | $9.84 | $41,869.20 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 3 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,850 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,027 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · derivative · entry 7 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,973 Underlying: Common Stock · 2,027 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,027 | $40.10 | $81,278.65 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 F1 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $41.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 23:19 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 2,027 | $9.84 | $19,945.68 |
DisclosureSEC source: 0000898432-21-000730 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · COO, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,622 Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 23:22 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 5,084 | $29.50 | $149,978.00 |
DisclosureSEC source: 0000898432-21-000567 · form4.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Financ. & Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,084 Underlying: Common Stock · 5,084 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in over four years in annual installments, each equal to 25% of the RSU Grant, with the first installment vesting twelve (12) months from the effective date, July 8, 2021, and the second, third and fourth installments vesting respectively 24, 36 and 48 months from the effective date, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in over four years in annual installments, each equal to 25% of the RSU Grant, with the first installment vesting twelve (12) months from the effective date, July 8, 2021, and the second, third and fourth installments vesting respectively 24, 36 and 48 months from the effective date, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-001025 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-001025 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,731 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · derivative · entry 8 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,195 Underlying: Common Stock · 2,731 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F6 · derivative.expiration_date: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · derivative · entry 7 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150 Underlying: Common Stock · 1,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On December 7, 2018, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F5 · derivative.expiration_date: On December 7, 2018, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantPerformance-Based Restricted Stock Units · Derivative | 5,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · derivative · entry 6 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,093 Underlying: Common Stock · 5,093 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F4 · derivative.exercise_date: The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2020 through December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. F4 · derivative.expiration_date: The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2020 through December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 5,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · derivative · entry 5 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,094 Underlying: Common Stock · 5,094 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,731 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · nonDerivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 02:12 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000866 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 02:12 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 719 | $24.90 | $17,903.10 |
DisclosureSEC source: 0000898432-20-000866 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,265 Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 02:12 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000866 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2019 Filed Jan 4, 2020 00:32 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000020 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2019 Filed Jan 4, 2020 00:32 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 662 | $23.38 | $15,477.56 |
DisclosureSEC source: 0000898432-20-000020 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,032 Read SEC document |
| December 31, 2019 Filed Jan 4, 2020 00:32 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000020 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 833 | $25.67 | $21,383.11 |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,978 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 16, 2020 21:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 1,344 | $24.59 | $33,048.96 |
DisclosureSEC source: 0000898432-20-001025 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · derivative · entry 4 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,725 Underlying: Common Stock · 1,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 10,926 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,926 Underlying: Common Stock · 10,926 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 384 | $22.88 | $8,785.92 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,394 Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,574 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 665 | $24.54 | $16,319.10 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · nonDerivative · entry 4 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,522 Read SEC document |
| December 07, 2019 Filed Dec 10, 2020 02:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 384 | $24.54 | $9,423.36 |
DisclosureSEC source: 0000898432-20-000871 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,456 Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 01:31 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001355 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,904 Underlying: Common Stock · 2,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.